chartexchange

Pivotal Phase 2 Rezatapopt PYNNACLE Data to Be Featured in Late-Breaking Oral Presentation at ENA 2026

GlobeNewswire Inc. | Nov 4, 2026 8:00 AM EST

Late-breaking oral presentation to highlight efficacy data across tumor types and in the ovarian cancer primary analysis population Late-breaking oral presentation to highlight efficacy data across tumor types and in the ovarian cancer primary analysis population

Read original article